Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1995
06/15/1995WO1995016032A1 ANTISENSE NUCLEIC ACID FOR THE TREATMENT OF DISEASES IN WHICH EXPRESSION OF bFGF, PDGF-A OR PDGF-B PLAYS A PATHOGENIC ROLE
06/15/1995WO1995016030A1 Purification of vitamin-k dependent proteins by membrane chromatography
06/15/1995WO1995016025A1 Glucose responsive insulin secreting beta-cell lines and method for producing same
06/15/1995WO1995015980A1 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015978A1 Pretargeting methods and compounds
06/15/1995WO1995015976A1 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
06/15/1995WO1995015975A1 Biologically active compounds
06/15/1995WO1995015973A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995WO1995015769A1 Preparation and use of immunoconjugates
06/15/1995WO1995015767A1 Long-acting injection suspensions and a process for their preparation
06/15/1995WO1995015766A1 Antiviral peptides
06/15/1995WO1995015765A1 Peptides to overcome inhibition of nerve growth
06/15/1995WO1995015764A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995WO1995015747A1 Local delivery of fibrinolysis enhancing agents
06/15/1995WO1995014100A3 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
06/15/1995WO1995014089A3 Cck-2, a receptor tyrosine kinase
06/15/1995WO1995014028A3 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
06/15/1995WO1995013297A3 Improved immunogenic compositions against human gastrin 17
06/15/1995WO1995012678A3 Improvements relating to cancer therapy
06/15/1995WO1995007108A3 Formulations for delivery of osteogenic proteins
06/15/1995CA2178622A1 Humanized antibodies and uses thereof
06/15/1995CA2178621A1 Glucose responsive insulin secreting beta-cell lines and method for producing same
06/15/1995CA2178477A1 Pretargeting methods and compounds
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2178345A1 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome
06/15/1995CA2177840A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995CA2177835A1 Methods and compositions for the suppression of neu mediated transformation
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2177471A1 Ifn-.gamma.receptor .beta.-chain and derivatives thereof
06/15/1995CA2177464A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/15/1995CA2175078A1 Process for the production of combinatorial compound libraries
06/14/1995EP0657541A1 Novel entities for cancer therapy
06/14/1995EP0657540A1 Novel entities for cancer therapy
06/14/1995EP0657539A1 Novel entities for cancer therapy
06/14/1995EP0657536A1 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding
06/14/1995EP0657534A1 Antiallergic agent
06/14/1995EP0657533A1 Monoclonal antibodies with high cytotoxicity against the human CD16 antigen, and bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody
06/14/1995EP0657520A1 Antioxidant
06/14/1995EP0657471A1 Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours
06/14/1995EP0657469A1 L-Selectin cleavage site, methods of diagnosis and usage thereof
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657467A1 Antitumor antibiotics
06/14/1995EP0657453A1 Angiotensin converting enzyme (ace) inhibitors containing a fused multiple ring lactam
06/14/1995EP0657174A1 Use of somatostatin
06/14/1995EP0657170A1 Products for the application of high initial doses of cetrorelix and preparation of a combined package for use in treating diseases
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656952A1 Cationic peptides and method for production
06/14/1995EP0656950A1 Tat-derived transport polypeptides
06/14/1995EP0656949A1 Vaccinia virus b15r used in interleukin b1-involving condition
06/14/1995EP0656947A1 Human interleukin-13
06/14/1995EP0656945A1 Stress protein epitopes
06/14/1995EP0656944A1 Human melanocyte stimulating hormone receptor
06/14/1995EP0656908A1 Use of specific binding molecules in potentiating igf-i activity
06/14/1995EP0656907A1 Conformationally restricted mimetics of reverse turns and peptides containing the same
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656904A1 Peptide inhibitors of selectin binding
06/14/1995EP0656903A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase
06/14/1995EP0656902A1 Peptide lung surfactants and therapeutic combinations
06/14/1995EP0656887A1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
06/14/1995EP0656790A1 Compositions and methods for modulating rna
06/14/1995EP0656789A1 Method for treating a lfa-1-mediated disorder
06/14/1995EP0656788A1 Hla binding peptides and their uses
06/14/1995EP0656787A1 Method of inhibiting reduction of disulfide bonds
06/14/1995EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
06/14/1995EP0656785A1 Method for inhibiting hiv replication using il-4
06/14/1995EP0656784A1 Parathyroid hormone fragments and analogs
06/14/1995EP0656782A1 Nutritional product for persons having a neurological injury
06/14/1995EP0656778A1 ENANTIOMERICALLY PURE $g(b)-D-DIOXOLANE-NUCLEOSIDES
06/14/1995EP0656767A1 Method of regenerating articular cartilage
06/14/1995EP0583352A4 -i(IN VITRO) METHODS FOR DETERMINING -i(IN VIVO) THROMBOTIC EVENTS.
06/14/1995EP0494260B1 Granulocyte-colony stimulating factor receptors
06/14/1995EP0442982B1 Topical compositions containing lycd and other topically active medicinal ingredients
06/14/1995DE4402867C1 Liposome(s) contg. encapsulated protein for pharmaceutical or cosmetic use
06/14/1995DE4342846A1 Peptide(s) or their derivs. binding to tumour-necrosis factor alpha
06/14/1995DE4339533A1 Detection of human double minute gene 2 (hdm-2) antibodies
06/14/1995DE4338817A1 Gene sequences for cellular X binding proteins isolated from mouse
06/13/1995US5424426 Dithiolanylglycine-containing HIV protease inhibitors of the hydroxyethylene isostere type
06/13/1995US5424425 Analgesics, antidepressants, hypotensive agent and treats irritable bowel syndrome and congestive heart failure
06/13/1995US5424409 DNA constructs encoding Bacillus thuringiensis toxins from strain A20
06/13/1995US5424408 For detection, removal of Goodpasture antibodies in blood; autoimmune diseases
06/13/1995US5424401 Absorbing enzymatic impurities which has amidolytic and proteolytic activity which degrade the blood factor 8, by pretreating with a solution containg aluminum hydroxide and basic ion exchange resin as absorbents
06/13/1995US5424400 Senescent cell derived inhibitors of DNA synthesis
06/13/1995US5424399 Recombinant heterodimer comprising extracellular domains of human complement receptor type 3 alpha and beta; inhibits CR3-mediated immune response
06/13/1995US5424396 Containing three to six amino acids
06/13/1995US5424395 Antimicrobial peptides active against plant pathogens
06/13/1995US5424394 Synthetic preparation of amylin and amylin analogues
06/13/1995US5424309 Hypotensive agents
06/13/1995US5424299 Composition and method for rejuvenating enteral feeding tubes
06/13/1995US5424293 Phenylimidazolidine derivatives and their use
06/13/1995US5424292 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases
06/13/1995US5424291 Isosteric peptides
06/13/1995US5424290 Amphiphilic polypeptide containing 21 to 26 amino acids inhibits growth of target cells, viruses and virally-infected cells
06/13/1995US5424289 Solid formulations of therapeutic proteins for gastrointestinal delivery
06/13/1995US5424287 A pure protein-based extract prepared by alkaline extraction a bacterial suspension at a PH between 11 to 13; stimulants for production of prostaglandins, anticarcinogenic agents; immunology
06/13/1995US5424286 Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
06/13/1995US5424218 Measuring binding affinity of compound to omega conotoxin binding site and ability to inhibit voltage-gated calcium currents or neurotransmitter release
06/13/1995US5424208 Contacting connective tissue containing viable cells with collagenase and chymopapain to hydrolyze the connective tissue
1 ... 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 2860 2861 2862 ... 3163